Probiotics combined with rifaximin influence the neurometabolic changes in a rat model of type C HE
Abstract Type C hepatic encephalopathy (HE) is a neuropsychiatric disease caused by chronic liver disease. Management of type C HE remains an important challenge because treatment options are limited. Both the antibiotic rifaximin and probiotics have been reported to reduce the symptoms of HE, but l...
Saved in:
Main Authors: | Emmanuelle Flatt, Valérie A. McLin, Olivier Braissant, Katarzyna Pierzchala, Paola Mastromarino, Stefanita-Octavian Mitrea, Dario Sessa, Rolf Gruetter, Cristina Cudalbu |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/a7ef8e8b4f0c43e88d7e80c9cb740c5a |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Probiotics improve the neurometabolic profile of rats with chronic cholestatic liver disease
by: Veronika Rackayová, et al.
Published: (2021) -
Rifaximin in the treatment of hepatic encephalopathy
by: Iadevaia MD, et al.
Published: (2011) -
Approach to Neurological Channelopathies and Neurometabolic Disorders in Newborns
by: Inn-Chi Lee
Published: (2021) -
Dysregulated miRNAs and their pathogenic implications for the neurometabolic disease propionic acidemia
by: Ana Rivera-Barahona, et al.
Published: (2017) -
An analysis framework for the integration of broadband NIRS and EEG to assess neurovascular and neurometabolic coupling
by: P. Pinti, et al.
Published: (2021)